Gutiérrez GG, Díaz-Manera J, Almendrote M, Azriel S, Bárcena JE, García PC, et al. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert’s disease. Med Clínica Engl Ed. 2019;153:82-e1.

Google Scholar 

Theadom A, Rodrigues M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R, et al. Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology. 2014;43:259–68.

Article  PubMed  Google Scholar 

Harper PS. Trinucleotide repeat disorders. J Inherit Metab Dis. 1997;20:122–4.

Article  CAS  PubMed  Google Scholar 

Martorell L, Monckton DG, Sanchez A, Lopez De Munain A, Baiget M. Frequency and stability of the myotonic dystrophy type 1 premutation. Neurology. 2001;56:328–35.

Article  CAS  PubMed  Google Scholar 

Vazquez JA, Pinies JA, Martul P, De los Rios A, Gatzambide S, Busturia MA. Hypothalamic-pituitary-testicular function in 70 patients with myotonic dystrophy. J Endocrinol Invest. 1990;13:375–9.

Article  CAS  PubMed  Google Scholar 

Hortas ML, Castilla JA, Gil MT, Molina J, Garrido ML, Morell M, et al. Decreased sperm function of patients with myotonic muscular dystrophy. Hum Reprod Oxf Engl. 2000;15:445–8.

Article  CAS  Google Scholar 

Puy V, Mayeur A, Levy A, Hesters L, Raad J, Monnot S, et al. CTG expansion in the DMPK gene: semen quality assessment and outcome of preimplantation genetic diagnosis. J Clin Endocrinol Metab. 2020;105(3):dgaa041.

Feyereisen E, Amar A, Kerbrat V, Steffann J, Munnich A, Vekemans M, et al. Myotonic dystrophy: does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation? Hum Reprod Oxf Engl. 2006;21:175–82.

Article  CAS  Google Scholar 

Sahu B, Ozturk O, Deo N, Fordham K, Ranierri M, Serhal P. Response to controlled ovarian stimulation and oocyte quality in women with myotonic dystrophy type I. J Assist Reprod Genet. 2008;25:1–5.

Article  PubMed  PubMed Central  Google Scholar 

Srebnik N, Margalioth EJ, Rabinowitz R, Varshaver I, Altarescu G, Renbaum P, et al. Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy. Reprod Biomed Online. 2014;29:94–101.

Article  CAS  PubMed  Google Scholar 

Van Der Kelen A, Santos-Ribeiro S, De Vos A, Verdyck P, De Rycke M, Berckmoes V, et al. Parameters of poor prognosis in preimplantation genetic testing for monogenic disorders. Hum Reprod Oxf Engl. 2021;36:2558–66.

Article  Google Scholar 

Dechanet C, Castelli C, Reyftmann L, Coubes C, Hamamah S, Hedon B, et al. Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype. Reprod Biomed Online. 2010;20:610–8.

Article  CAS  PubMed  Google Scholar 

Fernández RM, Lozano-Arana MD, Sánchez B, Peciña A, García-Lozano JC, Borrego S, et al. Preimplantation genetic diagnosis for myotonic dystrophy type 1 and analysis of the effect of the disease on the reproductive outcome of the affected female patients. BioMed Res Int. 2017;2017:9165363.

Sahu MT, Das V, Mittal S, Agarwal A, Sahu M. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet. 2010;281:215–20.

Article  PubMed  Google Scholar 

Parmova O, Vlckova E, Hulova M, Mensova L, Crha I, Stradalova P, et al. Anti-Müllerian hormone as an ovarian reserve marker in women with the most frequent muscular dystrophies. Medicine (Baltimore). 2020;99:e20523.

Article  CAS  PubMed  Google Scholar 

Sarkar PS, Paul S, Han J, Reddy S. Six5 is required for spermatogenic cell survival and spermiogenesis. Hum Mol Genet. 2004;13:1421–31.

Article  CAS  PubMed  Google Scholar 

Verpoest W, Seneca S, De Rademaeker M, Sermon K, De Rycke M, De Vos M, et al. The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract. J Assist Reprod Genet. 2010;27:327–33.

Article  PubMed  PubMed Central  Google Scholar 

Grynberg M, Labrosse J. Understanding follicular output rate (FORT) and its implications for POSEIDON Criteria. Front Endocrinol. 2019;10:246.

Article  Google Scholar 

Ashizawa T, Dubel JR, Harati Y. Somatic instability of CTG repeat in myotonic dystrophy. Neurology. 1993;43:2674–8.

Article  CAS  PubMed  Google Scholar 

Thornton CA. Myotonic dystrophy. Neurol Clin. 2014;32:705–19.

Butler R, Nakhuda G, Guimond C, Jing C, Lee N, Hitkari J, et al. Analysis of PGT-M and PGT-SR outcomes at a Canadian fertility clinic. Prenat Diagn. 2019;39:866–70.

Article  PubMed  Google Scholar 

Zanetti BF, de Braga DP, AF, Azevedo M de C, Setti AS, Figueira RCS, Iaconelli A, et al. Preimplantation genetic testing for monogenic diseases: a Brazilian IVF centre experience. JBRA Assist Reprod. 2019;23:99–105.

PubMed  PubMed Central  Google Scholar 

van Montfoort A, Carvalho F, Coonen E, Kokkali G, Moutou C, Rubio C, et al. ESHRE PGT Consortium data collection XIX-XX: PGT analyses from 2016 to 2017†. Hum Reprod Open. 2021;2021:hoab024.

Scott RT, Upham KM, Forman EJ, Zhao T, Treff NR. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil Steril. 2013;100:624–30.

Article  PubMed  Google Scholar 

Järvholm S, Thurin-Kjellberg A, Broberg M. Is pre-implantation genetic diagnosis (PGD) more of a strain regarding satisfaction with marital quality for male or female partners? A three-year follow-up study. J Psychosom Obstet Gynaecol. 2018;39:182–9.

Article  PubMed  Google Scholar